Anti-CD19 CAR T cells were among the last decade's scientific breakthroughs, achieving remarkable remissions in patients with B cell leukemias and lymphomas. Now, the engineered cell therapies are traversing disease indications into autoimmunity and resolving disease symptoms in patients with systemic lupus erythematosus (SLE), idiopathic inflammatory myositis, and systemic sclerosis..
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.stem.2024.03.006 | DOI Listing |
Publication Analysis
Top Keywords
car t cells
8
therapeutic intersections
4
intersections expanding
4
expanding benefits
4
benefits cd19
4
cd19 car
4
t cells cancer
4
cancer autoimmunity
4
autoimmunity anti-cd19
4
anti-cd19 car
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!